[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

SPMS- A Detailed Overview

September 2017 | 110 pages | ID: S861C416B44EN
Pharmascroll Research and Consulting Pvt Ltd

US$ 5,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report gives the overview of Secondary progressive multiple sclerosis disease indication in detail, highlights the SPMS epidemiology in the key geographies, elaborates on the drugs prescribed and expected to be prescribed in SPMS and covers the detailed market sizing drug wise and country wise in value sales and patient numbers along with forecast.
Multiple Sclerosis Definition
Types of MS
SPMS definition
Causes of SPMS
Profile of SPMS patient
Symptoms of SPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for SPMS
Drug Attribute analysis
Pipeline products in SPMS
SPMS Market sizing drug wise including value sales and patient numbers


More Publications